BBI608

Known as: BB608, BBI-608 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2017
012320152017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Napabucasin (BBI608) is an orally administered small molecule that blocks stem cell activity in cancer cells by targeting the… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
Cancer is a leading cause of mortality in the world and metastasis is to blame. Invasion is the initial step of metastasis… (More)
Is this relevant?
2017
2017
OBJECTIVE Patient-derived organoids (PDOs), used in multiple tumor types, have allowed evaluation of tumor characteristics from… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Partial or even complete cancer regression can be achieved in some patients with current cancer treatments. However, such initial… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Review
2015
Review
2015
s) 31 (Suppl. 15), 2542 (2013) | Hitron, M. et al. A Phase 1b study of the cancer stem cell inhibitor BBI608 administered with… (More)
Is this relevant?